| | 
Part, Chapter, Paragraph
1 I, 2. 10. 1 | toxicogenomics) or the impact o food on human health (nutrigenomics).
2 II, 5. 2. 4 | hypertension prevalence ( 160 o 95 mmHg; 140 o 90 mmHg;
3 II, 5. 2. 4 | prevalence ( 160 o 95 mmHg; 140 o 90 mmHg; 160 mmHg).~Table
4 II, 5. 2. 6 | Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy
5 II, 5. 5. 1 | health policies in the EU.~o Putting Mental Health on
6 II, 5. 5. 1 | European Agenda (1998-2000).~o Integrating Mental health promotion
7 II, 5. 5. 1 | through~ these programmes.~o Mental health promotion
8 II, 5. 5. 1 | health of young children.~o Supporting Children in Substance
9 II, 5. 5. 1 | Abuse Families (2002-3).~o Mental health promotion
10 II, 5. 5. 1 | interventions for schools.~o Mental health promotion
11 II, 5. 5. 1 | working age and older people.~o Implementation of Mental
12 II, 5. 5. 1 | prevention and services.~o The establishment of a Set
13 II, 5. 5. 1 | health and health systems.~o The European Review of Suicide
14 II, 5. 5. 1 | epidemiological trends.~o The Report of the State
15 II, 5. 5. 1 | in several Member States.~o Mental Health Information
16 II, 5. 5. 3 | Settertobulte W, Samdal O, Barnekow Rasmussen V, eds.
17 II, 5. 5. 3 | Graaf R, Ormel J, Gureje O, Shen Y, Huang Y, Zhang
18 II, 5. 5. 3 | G, Karlsson H, Bjarnason O, Bengtsson-Tops A, Dybbro
19 II, 5. 5. 3 | 000 in prevalence studies (O’Donogue and Sander, 1997)
20 II, 5. 5. 3 | patients. Epilepsia 44:575-581.~O’Donogue MF, Sander JW (1997):
21 II, 5. 5. 3 | Sillanpaa M, Jalava M, Kaleva O, Shinnar S (1998): Long-term
22 II, 5. 5. 3 | Aldenkamp A, Dreifuss F, Renier O, et al) Boca Raton, FL:
23 II, 5. 5. 3 | European-level lobbying by:~o determining the general
24 II, 5. 5. 3 | not at risk for job loss);~o identifying demographic
25 II, 5. 5. 3 | unemployed people with MS;~o identifying factors that
26 II, 5. 5. 3 | to stay in the workforce;~o assess the impact of a variety
27 II, 5. 5. 3 | 7. References~ ~Bajenaru O, Pascu I (2004): Report
28 II, 5. 5. 3 | Boiko A, Deomina T, Favorova O, Gusev E, Sudomoina M, Turetskaya
29 II, 5. 5. 3 | PA, Fredrikson M, Axelson O, Granérus AK (1999): Nutritional
30 II, 5. 5. 3 | Traficante R, Reid WG, O’Sullivan DJ, Williamson
31 II, 5. 5. 3 | Oertel W, Poewe W, Rascol O, Sampaio C (2006): Review
32 II, 5. 5. 3 | Neurosci 27(9):561-568.~Riedel O, Klotsche J, Spottke A,
33 II, 5. 5. 3 | 30(3):250-255~Schöffski O, v.d. Schulenburg J-M.,
34 II, 5. 5. 3 | Spottke AE, Reuter M, Machat O, Bornschein B, von Campenhausen
35 II, 5. 5. 3 | MD, Atkinson EJ, Cha RH, O’Brien PC (1993): Levodopa
36 II, 5. 6. 3 | 23% and 19% respectively (O’Neill et al, 2001). There
37 II, 5. 6. 3 | countries in the EVOS study (O’Neill et al, 2001). Vertebral
38 II, 5. 6. 3 | of men and 19% of women (O’Neill et al, 2001; Sernbo
39 II, 5. 6. 6 | Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ, III (
40 II, 5. 6. 6 | M, Nieminen P, Koivisto O (1994): More evidence from
41 II, 5. 6. 6 | Health and Welfare)~ ~Johnell O, Kanis JA, Oden A, Sernbo
42 II, 5. 6. 6 | 1323-1332~Kanis JA, Johnell O, Oden A, De Laet C, Jonsson
43 II, 5. 6. 6 | 251-258~Kanis JA, Johnell O, Oden A, Jonsson B, De Laet
44 II, 5. 6. 6 | 590~Kanis JA and Johnell O (2005): Requirements for
45 II, 5. 6. 6 | Linos A, Worthington JW, O'Fallon WM, Kurland LT (1980):
46 II, 5. 6. 6 | Nessiøy I, Bruusgaard D, Rutle O (1995): Musculoskeletal
47 II, 5. 6. 6 | Clin Rheumatol 15:27-48~O'Neill TW, Cooper C, Finn
48 II, 5. 6. 6 | 1020-1030~Sernbo I, Johnell O (1993): Consequences of
49 II, 5. 7. 7 | J, McLaughlin JK, Nyren O (2006): Obesity and risk
50 II, 5. 7. 7 | 9):1824-33.~Stevens PE, O'donoghue DJ, de LS, Van
51 II, 5. 8. 7 | Molstad S, Zetterstrom O. (2004): Early detection
52 II, 5. 10. 7 | Petrovsky N, Gendel SM, Gigonzac O, Stelman SJ (2003): Allergen
53 II, 5. 10. 7 | 13: 741-747.~Strannegard O and Strannegard IL (2001):
54 II, 5. 11. 3 | 45.~CS Jensen, S Lisby, O Baadsgaard, A Vølund, T
55 II, 5. 11. 3 | 108.~R Silva, F Pere a, O Bord o, E Silva, A Barr ,
56 II, 8. 2. 1 | 325.~Scheepers M, Kerr M, O’Hara D, Bainbridge D, Cooper
57 II, 8. 2. 1 | Haveman, M., Jørgensen, F., & O’Farrell, L., (2005). Brief
58 II, 9. 1. 1 | S78-87.~ ~Alran S, Sibony O, Oury JF, Luton D, Blot
59 II, 9. 3. 2 | S78-87.~ ~Alran S, Sibony O, Oury JF, Luton D, Blot
60 II, 9. 3. 3 | N, Guillaume A, Kontula O (2003): Reproductive behaviour
61 II, 9. 3. 3 | 533-49.~Bozon M, Kontula O (1998): Sexual initiation
62 II, 9. 3. 3 | Settertobultr W, Samdal O, Barnekow Rasmussen V (2004)
63 II, 9. 3. 3 | Haavio-Mannila E, Kontula O (2001): Seksin trendit meillä
64 II, 9. 3. 3 | Haavio-Mannila E, Kontula O (2003) Sexual trends in
65 III, 10. 1. 3 | Gendrop SC, Strickland O (1998): Competence and drug
66 III, 10. 2. 1 | 04_scenihr/docs/scenihr_o_013.pdf~ ~European Network
67 III, 10. 2. 1 | Adami H-O, Bofetta P, Nyrén O (2007): Oral use of Swedish
68 III, 10. 2. 1 | CD004148.pub3.~ ~Olsson O, Wikström PH (1982): Effects
69 III, 10. 2. 1 | children and adults (WHO, 1994; O’Mullane et al. 2004) Water
70 III, 10. 2. 1 | Athanossouli T, Holbrook WP, O'Mullane DM (2006): A European
71 III, 10. 2. 1 | Rev 2003; (1): CD002278.~ ~O’Mullane DM, Ketley CE, Cochran
72 III, 10. 2. 1(21)| Kapantais et al, 2004), Ireland (O’Neill et al, 2007; Whelton
73 III, 10. 2. 1(22)| Antal et al, 2004), Ireland (O’Neill et al, 2007; Whelton
74 III, 10. 2. 1 | Authority, 2004; Novakova, 2006; O’Neill et al, 2007; Padez
75 III, 10. 2. 1 | 27.3%, 9-12 years old) (O’Neill et al, 2007) and in
76 III, 10. 2. 1 | osteoporosis include:~ ~ ~o Calcium. Adequate calcium
77 III, 10. 2. 1 | Reference Intake (DRI)).~o Vitamin D. Because it is
78 III, 10. 2. 1 | per day may be sufficient.~o Physical activity. Bone
79 III, 10. 2. 1 | Settertobulte W, Samdal O, Barnekow Rasmussen V, eds (
80 III, 10. 2. 1 | do Carmo I, dos Santos O, Camolas J, Vieira J, Carreira
81 III, 10. 2. 1 | fbdg_2007.pdf]~ ~Ekholm O, Kjøller M, Davidsen M,
82 III, 10. 2. 1 | Metabolism 50:330-338.~ ~Katz DL, O’Connell M, Yeh MC, Nawaz
83 III, 10. 2. 1 | Nolan G, Sixsmith J, Walsh O, Cooke M (2003): The national
84 III, 10. 2. 1 | Republic (in Slovakian).~ ~O'Neill JL, McCarthy SN, Burke
85 III, 10. 2. 1 | Stan odzywienia w oparciu o pomiary antropometryczne
86 III, 10. 2. 4 | Burke, 2003; Ellsworth and O'Donnell, 2004): in the future
87 III, 10. 2. 4 | at: htt ~ ~Ellsworth DL, O’Donnell CJ (2004): Emerging
88 III, 10. 2. 4 | Zika E, Papatryfon I, Wolf O, Gómez-Barbero M, Stein
89 III, 10. 3. 1 | Downloadable from: htt /MENS_O&O_03.PDF~Villeneuve PJ,
90 III, 10. 3. 1 | Downloadable from: htt /MENS_O&O_03.PDF~Villeneuve PJ, Morrison
91 III, 10. 4. 1 | included:~ ~· Chronic exposure:~o Mortality (PM) – the dominant
92 III, 10. 4. 1 | PM) – the dominant effect~o Development of bronchitis (
93 III, 10. 4. 1 | exposure (daily variations)~o Mortality (O3 )~o Hospital
94 III, 10. 4. 1 | variations)~o Mortality (O3 )~o Hospital admissions~ ~·
95 III, 10. 4. 1 | O3); Cardiovascular (PM)~o Days of restricted activity;
96 III, 10. 4. 1 | days off work (PM,O3 )~o Days with symptoms (PM,
97 III, 10. 5. 1 | Konlaan, B B. Bygren, L O. Johansson, S E. Visiting
98 III, 10. 5. 1 | 174-8, 2000 Sep.~Hänninen, O, Palonen, J, Tuomisto, JT,
99 III, 10. 5. 1 | Yli-Tuomi, T, Seppänen, O, Jantunen, MJ (2005): Reduction
100 III, 10. 5. 1 | Loftness V, Hakkinen B, Adan O, Nevalainen A (2007): Elements
101 III, 10. 5. 2 | from rural to urban areas (O`Reilly et al., 2007).~ ~
102 III, 10. 5. 2 | accessed on January 23, 2008)~ ~O'Reilly G, O'Reilly D, Rosato
103 III, 10. 5. 2 | 23, 2008)~ ~O'Reilly G, O'Reilly D, Rosato M, Connolly
104 IV, 12. 10 | Safety awareness~High~o An adequate number of Reporting
105 IV, 12. 10 | are running in Greece.~o Our National Organization
106 IV, 12. 10 | program of Pharmacovigilance~ ~o Greece participates in a
107 IV, 12. 10 | settings~Air pollution~ High~o Law 3010/2002 concerning
108 IV, 12. 10 | Directive 97/11 and 96/61~o Common Ministerial Decision
109 IV, 12. 10 | destroy the layer of ozone.~o Ministerial Decision 21475/
110 IV, 12. 10 | for containment of CO2~ ~o The Ministry of Environment,
111 IV, 12. 10 | and support this phase.~o The last 5-6 years citizens
112 IV, 12. 10 | discounts on connections fees)~o In Greece, all vehicles
113 IV, 12. 10 | updated at least every year.~o Also, the Ministry has developed
114 IV, 12. 10 | protection can be archived.~o Moreover, every day a Report
115 IV, 12. 10 | the site of the Ministry~o Useful information about
116 IV, 12. 10 | air protection measures.~o Finally, a campaign concerning “
117 IV, 12. 10 | and waste disposal~ High~o 01 regarding "Packaging
118 IV, 12. 10 | particular with the Euro 2.~o The Ministry for the Environment,
119 IV, 12. 10 | recovery of packaging waste.~o Law 3010/2002 «Updating
120 IV, 12. 10 | Directives 97/11 and 96/61.~o Common Ministerial Decision
121 IV, 12. 10 | partly funded by the E.U~o Common Ministerial Decision
122 IV, 12. 10 | National and Regional Planning”~o Presidential Degree 117/
123 IV, 12. 10 | equipment” of 27 January 2003.~ ~o The producers of Electric
124 IV, 12. 10 | chemical contaminants~ High~o Common Ministerial Decision
125 IV, 12. 10 | Management of Hazardous Waste”,~o Ministerial Decision 13588/
126 IV, 12. 10 | of 12th December 1991”.~o Presidential Degree 116/
127 IV, 12. 10 | 2939/01 about recycling.~o Especially for the management
128 IV, 12. 10 | high~ ~ ~Food safety~ high~o Law 2741/1999 concerning
129 IV, 12. 10 | Hellenic Food Authority (EFET)~o Common Ministerial Decision
130 IV, 12. 10 | be certified with HACCP~o Common Ministerial Decision
131 IV, 12. 10 | genetic modified organisms.~o Ministerial Decisions 34258
132 IV, 12. 10 | the E.U Regulation 93/99.~o Common Ministerial Decision
133 IV, 12. 10 | Code about road safety~ ~o Law 3542/2007 (in comparison
134 IV, 12. 10 | violation of the regulations.~o TV spots are used by the
135 IV, 12. 10 | events and health~ high~o The direction 1299/2003
136 IV, 12. 10 | determinants~Poverty~ high~o Recently (15/1/2008) the
137 IV, 12. 10 | estimated limits of poverty.~o Law 2434/1996 established
138 IV, 12. 10 | 000 eligible pensioners.~o The Greek State provides
139 IV, 12. 10 | Gender issues~ high~o Law 1329/1983: Modernization
140 IV, 12. 10 | principle of gender equality.~o Law 1414/1984: Gender equality
141 IV, 12. 10 | 117 and 76/207 of the EU.~o Law 2839/2000: Balanced
142 IV, 12. 10 | decision-making centers.~o Law 3488/2006: Enforcement
143 IV, 12. 10 | the working conditions.~o Law 3500/2006: Encounter
144 IV, 12. 10 | Work-related health issues~ high~o Law 1568/1985 “Health and
145 IV, 12. 10 | and Safety of employees”~o Presidential Degree 105/
146 IV, 12. 10 | Council Directive: 92/58~o Presidential Degree 16/1996 “
147 IV, 12. 10 | Council Directive 89/654’’.~o Presidential Degrees 88/
148 IV, 12. 10 | Directives 93/104, 2000/34’’~o Presidential Degrees 17/
149 IV, 12. 10 | Directives: 89/391 and 91/383~o Presidential Degrees 396/
150 IV, 12. 10 | 655, 89/655 respectively.~o Law 3227/2004 Concerning
151 IV, 12. 10 | Employment and Social Protection)~o The Greek Ministry of Employment
152 IV, 12. 10 | different themes, every year.~ ~o Especially concerning work-related
153 IV, 12. 10 | Objectives of the Program:~o Improving employability
154 IV, 12. 10 | relation to the labor market~o Developing entrepreneurship
155 IV, 12. 10 | strengthening the social economy~o Encouraging adaptability
156 IV, 12. 10 | adaptability of firms and employees~o Strengthening the equal
157 IV, 12. 10 | STRATEGIES AND REPORTS (GREECE)~ ~o The Law 3370 on 11th July
158 IV, 12. 10 | European Union and the WHO.~ ~o The Ministry of Health and
|
|
| |
